Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,350.40
(
-0.82%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
104.41
(
2.25%
)
Bitcoin
76,319.05
(
-1.36%
)
News Focus
News Focus

Replies to post #521242 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #521242 on NorthWest Biotherapeutics Inc (NWBO)
icon url

HyGro

10/13/22 2:55 AM

#521593 RE: Roman516 #521242

And you missed that NWBO announced they failed to meet the original primary endpoint of their Phase 3 clinical trial. No biotech investors bought the TLD from that point on and the share price showed no positive response to the TLD.